Thursday, September 22, 2022 3:35:05 PM
The ones that still have job...
We are now trading at the cash price/share price they raised 12 Million dollars plus the payment 1.5 Mil net(?) and collected in the last 4 years,
12 Mil shares (12.8x now?) at almost a $1.share for a biotech with a decade of what, 100 Million dollars of research work, they own now valued at 12 Mil dollars? I know .01/share penny stocks with higher Market caps...
This is either nuts, way undervalued and they are raising major $$$$ cash and we just have not heard the news yet, or the market is pricing this for BK, in which case the 12 mil cash raise weeks ago and R/S and so on make no sense...
Hell most folks can not even short it now.... The revenue to share price is close 1:2 also... This is at least a FED Market exit from anything with debt now...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM